ClinicalTrials.gg
Sign In

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Resilient Pharmaceuticals clinical trials

Also known as Lykos, MAPS PBC.

The registry lists 30 studies whose lead sponsor is Resilient Pharmaceuticals or one of 1 company grouped under it. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 29, 2026.

Keep track of what changes. Save the Resilient Pharmaceuticals studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed
20
Withdrawn
4
Terminated
3
No longer available
1
Active, not recruiting
1
Not yet recruiting
1

Phase

Phase 2
17
Phase 1
7
Phase 3
3

Where

United States
21
Israel
6
Canada
5
Switzerland
1

Registry sponsor names on this page

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Resilient Pharmaceuticals.

  • Lykos Therapeutics
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    28 studies →
  • Resilient Pharmaceuticals
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies

Focus areas

Conditions Resilient Pharmaceuticals leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Stress Disorders, Post-Traumatic16

Studies

Recruiting first, then most recently updated. Showing 30 of 30.